Sunshine Biopharma, Inc. (SBFM)

Sunshine Biopharma Revenue

Sunshine Biopharma had revenue of $26.74M in the twelve months ending March 31, 2024, with 193.30% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.54M with 54.09% year-over-year growth. In the year 2023, Sunshine Biopharma had annual revenue of $24.09M with 454.42% growth.

• Revenue (ttm): $26.74M
• Revenue Growth: +193.30%
• P/S Ratio: 0.26
• Revenue / Employee: $607,722
• Employees: 44
• Market Cap: 6.88M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	24.09M	19.75M	454.42%
Dec 31, 2022	4.35M	4.12M	1,802.41%
Dec 31, 2021	228.43K	157.02K	219.88%
Dec 31, 2020	71.41K	50.29K	238.10%
Dec 31, 2019	21.12K	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	1.71K	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-
Dec 31, 2010	0	-	-
Jul 31, 2009	0	-	-
Jul 31, 2008	0	-	-
Jul 31, 2007	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.